TrialAntimicrobial agents and chemotherapy2000

A population pharmacokinetic analysis of nelfinavir mesylate in human immunodeficiency virus-infected patients enrolled in a phase III clinical trial.

K A Jackson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.